Certified by Founder Lodge
Enavate Sciences
United States - ND INVESTOR
1 Disclosed Funding Rounds $100,000,000
6 Participating Investments
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
Enavate Sciences is a platform dedicated to supporting therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient need. Through the a
| Company | Date | Round | Raised |
|---|---|---|---|
 CAMP4 Therapeutics | July, 20 ,2022 | Series B | $100,000,000 |
 OrsoBio | November, 08 ,2023 | Series A | $60,000,000 |
 Sudo Biosciences | December, 21 ,2023 | Series B | $116,000,000 |
 Sionna Therapeutics | March, 07 ,2024 | Series C | $182,000,000 |
 Aviceda Therapeutics | January, 08 ,2025 | Series C | $207,500,000 |
 Normunity | January, 14 ,2025 | Series B | $75,000,000 |
Patchwork Health
Abridge
Salvo Health
CareBridge
Health Note
Further AI | $5,000,000 | (Apr 3, 2025)
SchoolAI | $25,000,000 | (Apr 3, 2025)
Vivere | $7,500,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
TwinKnowledge | $3,700,000 | (Apr 3, 2025)
